NM_005850.5:c.1153_1159dupTACACTG
Variant summary
Our verdict is Likely pathogenic. Variant got 6 ACMG points: 6P and 0B. PVS1_ModeratePM2PP5_Moderate
The NM_005850.5(SF3B4):c.1153_1159dupTACACTG(p.Gly387ValfsTer101) variant causes a frameshift change. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Pathogenic (★).
Frequency
Consequence
NM_005850.5 frameshift
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 6 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 32
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not provided Pathogenic:1
The c.1153_1159dupTACACTG duplication in the SF3B4 gene has not been reported previously as a pathogenic variant nor as a benign polymorphism, to our knowledge. The c.1153_1159dupTACACTG duplication causes a frameshift starting with codon Glycine 387, changes this amino acid to a Valine residue, and creates a premature Stop codon at position 101 of the new reading frame, denoted p.Gly389ValfsX101. This frameshift variant replaces the typical last 38 amino acid residues in the SF3B4 protein with 100 different amino acid residues, which is expected to alter the normal structure and function of the resultant protein. The c.1153_1159dupTACACTG duplication was not observed in approximately 6,500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. We interpret c.1153_1159dupTACACTG as a pathogenic variant. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at